专利检索 ap:("DCB-USA LLC" OR "DEVELOPMENT CENTER FOR BIOTECHNOLOGY") AND inv:"Paonien Chen" 第 1 页

1.

发明授权
Pyrimidine compounds as mTOR and PI3K inhibitors 有权

公开(公告)号：US09801888B2

公开(公告)日：2017-10-31

申请号：US15002806

申请日：2016-01-21

申请人： DEVELOPMENT CENTER FOR BIOTECHNOLOGY , DCB-USA LLC

发明人： Mann-Yan Kuo , Ying-Shuan Lee , Paonien Chen , Li Jung Chen , Yann Yu Lu , Yi-Ting Huang , Hung-Yi Hsu , Ping-Kuei Tsai

IPC分类号： A61K31/5377 , A61K31/541 , C07D413/04 , C07D413/14 , C07D417/14 , C07D403/12 , C07D401/14 , C07D239/47 , C07D409/12 , C07D413/12 , A61K45/06 , C07D401/04

CPC分类号： A61K31/5377 , A61K31/541 , A61K45/06 , C07D239/47 , C07D401/04 , C07D401/14 , C07D403/12 , C07D409/12 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/14 , A61K2300/00

摘要： The present invention relates to pyrimidine compounds of formula (I): which are useful in treating mTOR kinase- or PI3K kinase-related diseases.

2.

发明申请
NOVEL PYRIMIDINE COMPOUNDS AS mTOR AND PI3K INHIBITORS 有权
标题翻译：新型吡咯烷酮化合物作为mTOR和PI3K抑制剂

公开(公告)号：US20140178360A1

公开(公告)日：2014-06-26

申请号：US14192301

申请日：2014-02-27

申请人： DCB-USA LLC , DEVELOPMENT CENTER FOR BIOTECHNOLOGY

发明人： Mann-Yan KUO , Ying-Shuan Lee , Paonien Chen , Li Jung Chen , Yann Yu Lu , Yi-Ting Huang , Hung-Yi Hsu , Ping-Kuei Tsai

IPC分类号： C07D413/04 , A61K31/541 , A61K45/06 , A61K31/5377 , C07D413/14 , C07D417/14

CPC分类号： A61K31/5377 , A61K31/541 , A61K45/06 , C07D239/47 , C07D401/04 , C07D401/14 , C07D403/12 , C07D409/12 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/14 , A61K2300/00

摘要： The present invention relates to pyrimidine compounds of formula (I): which are useful in treating mTOR kinase- or PI3K kinase-related diseases.

摘要翻译： 本发明涉及式（I）的嘧啶化合物：其可用于治疗mTOR激酶或PI3K激酶相关疾病。

3.

发明授权
Pyrimidine compounds as mTOR and PI3K inhibitors 有权
标题翻译：嘧啶化合物作为mTOR和PI3K抑制剂

公开(公告)号：US09315491B2

公开(公告)日：2016-04-19

申请号：US14192301

申请日：2014-02-27

申请人： DEVELOPMENT CENTER FOR BIOTECHNOLOGY , DCB-USA LLC

发明人： Mann-Yan Kuo , Ying-Shuan Lee , Paonien Chen , Li Jung Chen , Yann Yu Lu , Yi-Ting Huang , Hung-Yi Hsu , Ping-Kuei Tsai

IPC分类号： A61K31/5377 , C07D239/47 , A61K31/506 , C07D401/04 , C07D401/14 , C07D413/04 , A61K31/541 , A61K45/06 , C07D413/14 , C07D417/14 , C07D403/12 , C07D409/12 , C07D413/12

CPC分类号： A61K31/5377 , A61K31/541 , A61K45/06 , C07D239/47 , C07D401/04 , C07D401/14 , C07D403/12 , C07D409/12 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/14 , A61K2300/00

摘要： The present invention relates to pyrimidine compounds of formula (I): which are useful in treating mTOR kinase- or PI3K kinase-related diseases.

摘要翻译： 本发明涉及式（I）的嘧啶化合物：其可用于治疗mTOR激酶或PI3K激酶相关疾病。